Open Access
| Issue |
BIO Web Conf.
Volume 100, 2024
International Scientific Forum “Modern Trends in Sustainable Development of Biological Sciences” (IFBioScFU 2024)
|
|
|---|---|---|
| Article Number | 01014 | |
| Number of page(s) | 7 | |
| Section | Interdisciplinary Research in Biophysics, Biomedicine, and Neuroscience | |
| DOI | https://doi.org/10.1051/bioconf/202410001014 | |
| Published online | 08 April 2024 | |
- H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71, 209–249 (2021) https://doi.org/10.3322/caac.21660 [CrossRef] [PubMed] [Google Scholar]
- X. J. Cheng, J. C. Lin, S. P. Tu. Etiology and Prevention of Gastric Cancer. Gastrointest Tumors, 3 (1), 25–36 (2016) https://doi.org/10.1159/000443995 [CrossRef] [PubMed] [Google Scholar]
- R. Sitarz, M. Skierucha, J. Mielko, G. J. A. Offerhaus, R. Maciejewski, W. P. Polkowski. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res., 10, 239–248 (2018) https://doi.org/10.2147/CMAR.S149619 [CrossRef] [Google Scholar]
- M. Saito, H. Okayama, K. Saito, J. Ando, K. Kumamoto, I. Nakamura, et al. CDX2 is involved in microRNA-associated inflammatory carcinogenesis in gastric cancer. Oncol Lett., 14, 6184–6190 (2017) https://doi.org/10.3892/ol.2017.6956 [Google Scholar]
- E. Vakiani. HER2 testing in gastric and gastroesophageal adenocarcinoma. Adv Anat Pathol., 22 (3), 194–201 (2015) https://doi.org/10.1097/PAP.0000000000000067 [CrossRef] [PubMed] [Google Scholar]
- Y. Y. Lei, J. Y. Huang, Q. R. Zhao, N. Jiang, H.M. Xu, Z. N. Wang, H. Q. Li, S. B. Zhang, Z. Sun. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. World J Surg Oncol., 15(1), (2017) https://doi.org/10.1186/s12957-017-1132-5 [Google Scholar]
- A. K. Nagatsuma, M. Aizawa, T. Kuwata, T. Doi, A. Ohtsu, H. Fujii, A. Ochiai. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma. Gastric Cancer, 18, 227–238 (2015) https://doi.org/10.1007/s10120-014-0360-4 [CrossRef] [PubMed] [Google Scholar]
- S. Matsusaka, A. Nashimoto, K. Nishikawa Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101). Gastric Cancer 19, 1026 (2016). https://doi.org/10.1007/s10120-015-0576-y [CrossRef] [PubMed] [Google Scholar]
- M. Aznab, D. Maleksabet, S. Khazaei, M. Khazaei, M. Rezaei. The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer. Asian Pac J Cancer Prev. 20 (7), 1989–1994 (2019) https://doi.org/10.31557/APJCP.2019.20.7.1989 [CrossRef] [Google Scholar]
- M. Smolińska, D. Grzanka, P. Antosik, A. Kasperska, I. Neska-Długosz, J. Jóźwicki, A. Klimaszewska-Wiśniewska. HER2, NF-kB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological Parameters. Dis Markers. (2019):6315936. https://doi.org/10.1155/2019/6315936 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.